A novel nucleolin-binding peptide for Cancer Theranostics

Background: Cancer-specific ligands have been of great interest as pharmaceutical carriers due to the potential for site-specific delivery. In particular, cancer-specific peptides have many advantages over nanoparticles and antibodies, including high biocompatibility, low immunogenicity, and the for...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae-Hyun, Bae, Chanhyung, Kim, Min-Jung, Song, In-Hye, Ryu, Jae-Ha, Choi, Jang-Hyun, Lee, Choong-Jae, Nam, Jeong-Seok, Kim, Jae Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415810/
https://www.ncbi.nlm.nih.gov/pubmed/32802184
http://dx.doi.org/10.7150/thno.43502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415810/
https://www.ncbi.nlm.nih.gov/pubmed/32802184
http://dx.doi.org/10.7150/thno.43502

Ejemplares similares